AP NEWS

Global Bioresorbable Scaffolds Strategic Business Report 2018: Analysis & Forecasts (2016-2024) - Spurt in Medical Tourism Offers Growth Opportunities - ResearchAndMarkets.com

July 11, 2018

DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Bioresorbable Scaffolds - Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.

This report analyzes the worldwide markets for Bioresorbable Scaffolds in US$ Thousand.

The report profiles 17 companies including many key and niche players such as:

Abbott Laboratories (USA) Amaranth Medical, Inc. (USA) Arterial Remodeling Technologies SA (France) BIOTRONIK SE & Co. KG (Germany) Elixir Medical Corp. (USA) Kyoto Medical Planning Co., Ltd. (Japan) REVA Medical, Inc. (USA)

Key Topics Covered

1. Industry Overview

2. Absorb III Trials

3. Growth Drivers & Market Trends

Global Menace of Coronary Artery Disease (CAD) - A Major Growth Driver Ageing Demographics and Longer Life Expectancy Bolsters Market Growth Rising Middle Class Population Aids Growth Rising Healthcare Expenditure: Opportunities in Store Risk of CAD in Obesity Offers Prospects for Coronary Stenting Diabetics at Higher Risk of Heart Diseases The Hypertension-Cholesterol Link to Drive Demand Spurt in Medical Tourism Offers Growth Opportunities Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents Metal Stents Vis-a-vis Other Stents Alternative Therapies/Devices: Threats to Coronary Stents Cell Transplantation - A Threat to Coronary Stents

4. Pipeline Analysis

5. Regulatory Framework

6. Product Overview

7. Recent Industry Activity

8. Clinical Trials and Product Approvals

9. Focus on Select Global Players

10. Global Market Perspective

Total Companies Profiled: 17 (including Divisions/Subsidiaries 18)

The United States (6) Japan (1) Europe (5) France (1)Germany (2)The United Kingdom (1)Rest of Europe (1) Asia-Pacific (Excluding Japan) (6)

For more information about this report visit https://www.researchandmarkets.com/research/nxtxvd/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005720/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Stents,Biomaterials

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/11/2018 01:42 PM/DISC: 07/11/2018 01:42 PM

http://www.businesswire.com/news/home/20180711005720/en

AP RADIO
Update hourly